Pulmonary Rehabilitation in Patients with COVID-19-A Protocol for Systematic Review and Meta-Analysis

Yanan Gao1, Huiming Huang1, Chunxia Ni1

  • 1Faculty of Sport Science, Research Academy of Grand Health, Ningbo University, Ningbo 315211, China.

Insights

This systematic review protocol outlines the first worldwide assessment of pulmonary rehabilitation (PR) for COVID-19 patients. It details methods to evaluate PR

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Evidence-Based Medicine
  • Systematic Review Methodology

Background:

  • Pulmonary rehabilitation (PR) is a standard treatment for chronic lung diseases.
  • The efficacy of PR specifically for patients recovering from COVID-19 requires systematic investigation.

Purpose of the Study:

  • To conduct the first global systematic review and meta-analysis on the effects of pulmonary rehabilitation in COVID-19 patients.
  • To establish the impact of PR on key patient outcomes post-COVID-19.

Main Methods:

  • Systematic review protocol registered on PROSPERO (CRD42022301418).
  • Comprehensive search of five major databases (PubMed, Web of Science, Cochrane, EBSCO, CNKI) from 2019 to July 2022.
  • Eligibility criteria defined using the PICOS framework; primary outcomes include pulmonary function, exercise capacity, and quality of life.
  • Quantitative data synthesis via narrative synthesis and meta-analysis; qualitative data synthesis through argument and refutational analysis.

Main Results:

  • Results will be presented through both meta-analysis and qualitative synthesis.
  • This study aims to provide a comprehensive overview of existing evidence.

Conclusions:

  • This protocol details the methodology for a novel systematic review and meta-analysis.
  • The findings will inform clinical practice regarding the role of pulmonary rehabilitation in COVID-19 recovery.
  • Publication in a peer-reviewed journal and broad dissemination are planned.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
277
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
445